Charts Abbott Laboratories Deutsche Boerse AG
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
16:14:38 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 96.64 EUR | -0.98% |
|
-1.83% | -9.52% |
| 08-27 | Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing | MT |
| 08-27 | Abbott Laboratories' Stroke Treatment Device Receives CE Mark | MT |
Chart: Technical Analysis
Stock exchange
Deutsche Boerse AG
ABL 95.46 €
-2.19%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| ABT | 112.11USD | +0.47% | 264M $ | |
CBOE
| ABT | 112.21USD | +0.58% | 10.07M $ | |
Tradegate
| ABL | 96.56EUR | +0.81% | 123K € | |
London S.E.
| ABT | 112.75USD | -2.28% | 90.99K $ | |
Xetra
| ABL | 96.50EUR | +0.35% | 64.46K € | |
Boerse Muenchen
| ABL | 96.55EUR | +0.93% | 25.97K € | |
CBOE
| ABT | 95.54EUR | -0.73% | 9.55K € | |
Börse Stuttgart
| ABL | 96.46EUR | +0.86% | 8.3K € | |
CBOE
| 95.76EUR | -1.26% | 3.16K € | ||
Mexican S.E.
| ABT * | 1,970.00MXN | 0.00% | 21.67K $ | |
Kazakhstan S.E.
| ABT_KZ | 124.00USD | -1.43% | 620 $ | |
Swiss Exchange
| ABT | 90.50CHF | -2.69% | 0 CHF | |
Lima
| ABTUS | 110.37USD | 0.00% | 0 $ | |
Wiener Boerse
| ABT | 100.10EUR | +0.62% | 0 € | |
Santiago S.E.
| ABT | 110.37USD | 0.00% | 0 $ | |
Santiago S.E.
| ABTCL | 106,710.00CLP | +5.76% | 0 $ | |
Deutsche Boerse AG
| ABL | 95.46EUR | -2.19% | 0 € | |
Borsa Italiana
| 1ABT | 96.22EUR | -2.55% | 0 € | |
Sao Paulo
| ABTT34 | 48.57BRL | -2.37% | 1.21K R$ | |
Buenos Aires S.E.
| ABT | 46,440.00ARS | -0.43% | 147M $ | |
Buenos Aires S.E.
| ABTD | 30.14USD | -0.43% | 4.67K $ | |
Deutsche Boerse AG
| ABL0 | 12.00EUR | -2.44% | 0 € | |
Toronto S.E.
| ABT | 19.52CAD | -2.35% | 190K $ |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
- Charts Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions

















